Quick Clinical Summary
Retatrutide is an investigational triple hormone receptor agonist that targets pathways associated with significant weight reduction and metabolic health.
Research Applications
✚
Weight Management
↗
Glycemic Control
⇢
Appetite Suppression
Product Specifications
Purity
> 99.2% (HPLC Verified)
Molecular Weight
N/A
Formulation
Lyophilized White Powder
Storage
-20°C Long-term / 4°C Short-term
Mechanism Overview
Retatrutide 10 Synergy
Activates GLP-1, GIP, and glucagon receptors simultaneously to suppress appetite, improve insulin response, and increase energy expenditure.
Quality Assurance
HPLC/MS CertifiedVerified for purity and identity.
Aseptic ProcessingISO cleanroom facilities.
Batch VerificationDigital lab reports supported.
Vacuum SealedNitrogen purged for stability.
Research Disclaimer
This product is intended for laboratory research purposes only.